News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER at mid-year: 2026 progress and what’s ahead
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Feature
173 Results
173 Results
R3 Seminar Recap: RECOVER-SLEEP and RECOVER-ENERGIZE – Clinical Trials for Sleep Disturbances, Exercise Intolerance, and Post Exertional Malaise Due to Long COVID
During the June 25th RECOVER Research Review (R3) Seminar, researchers presented details about RECOVER-SLEEP, which included two trials focused on identifying potential treatments for sleep disturbances. Researchers also shared details about RECOVER-ENERGIZE, which included one trial focused on potential treatments for exercise intolerance and one trial examining potential treatments for post-exertional malaise. All the trials were recruiting adults experiencing one or more of these symptoms after having COVID. The presentation also included updates on other RECOVER clinical trials in progress.
R3 Seminar Recap
RECOVER researchers publish pediatric study design
The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Announcement
R3 Seminar Recap: SARS-CoV-2 infection during pregnancy and development of Long COVID
During the May 14th RECOVER Research Review (R3) Seminar, researchers presented findings from the RECOVER pregnancy observational cohort and EHR cohort about the association of SARS-CoV-2 infection during pregnancy and development of Long COVID.
R3 Seminar Recap
NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise
RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.
News Release
NIH RECOVER makes Long COVID research data easier to access
De-identified data from thousands of adults with Long COVID are now available to researchers.
News Release
R3 Seminar Recap: PASC in Children: State of the Science and Future Directions
During the April 23rd, RECOVER Research Review (R3) Seminar, the speakers discussed our current knowledge of Long COVID in children, including epidemiology and risk factors, symptoms, underlying mechanisms that cause symptoms, and functional outcomes.
R3 Seminar Recap
R3 Seminar Recap: Patterns and Prevention of Long COVID: Findings from RECOVER EHR Cohort Studies
During the March 19th RECOVER Research Review (R3) Seminar, research presented findings about vaccine effectiveness against Long COVID in children and the association between SARS-CoV-2 infection and symptoms and conditions in children and adults.
R3 Seminar Recap
NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction
RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
News Release